Sanofi-Aventis to take over Poland's Nepentes
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis's Polish subsidiary has launched a public tender offer to buy 100% of the Polish consumer healthcare company Nepentes in a deal valuing the latter at €105 million.